Search
for
Sort by
Research 391–420 of 542
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
- Vaccines, adjuvants and autoimmunity
- Use of diphenylcyclopropenone for alopecia areata treatment during pregnancy
- Immune therapies for alopecia areata: evidence and new perspectives
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol 0.05% in treatment of alopecia areata: A clinical and trichoscopic study
- Selective Expression of Chemokine Monokine Induced by Interferon-γ in Alopecia Areata
- Coexistence of dermatomyositis and alopecia areata: Insight into pathogenesis
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata
- The Role of Vitamin D in Autoimmune Thyroid Diseases: From Immunomodulation to Clinical Implications
- Impact of Vitamin D on Immunopathology of Hashimoto’s Thyroiditis: From Theory to Practice
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Annular alopecia areata: Report of two cases
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Exploring the effect of hsa-miR-19b-3p on IL-1R1 expression and serum levels in alopecia areata
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- Bacteroides fragilis and Microbacterium as Microbial Signatures in Hashimoto’s Thyroiditis
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Exploring the Gut Microbiome and Metabolome in Individuals with Alopecia Areata Disease
- Targeted immunotherapy for hair regrowth and regeneration
- Exploring the Role of Gut Microbiota in Patients with Alopecia Areata
- Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin
- Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate (DHEA-S) in the majority of the alopecia areata patients: Is it a primitive and pathogenic perturbation of hypothalamic-pituitary-adrenal axis?